Latest papers

Lipid-heparin infusion suppresses the IL-10 response to trauma in subcutaneous adipose tissue in humans.

Venous thromboembolism prophylaxis in surgical patients: identifying a patient group to maximize performance improvement.

Myocardial infarction with intracardiac thrombosis as the presentation of acute promyelocytic leukemia: diagnosis and follow-up by cardiac magnetic resonance imaging.

Heparin changes the conformation of high-mobility group protein 1 and decreases its affinity toward receptor for advanced glycation endproducts in vitro.

Six-month echocardiographic study in patients with submassive pulmonary embolism and right ventricle dysfunction: comparison of thrombolysis with heparin.

Heparin-immobilized microspheres for the capture of cytokines.

Analysis of glycosaminoglycans in stem cell glycomics.

Interrupted pharmocologic thromboprophylaxis increases venous thromboembolism in traumatic brain injury.

emIn vivo/em Liver Endocytosis Followed by Purification of Liver Cells by Liver Perfusion.

Heparin induces harmless fibril formation in amyloidogenic W7FW14F apomyoglobin and amyloid aggregation in wild-type protein in vitro.

Synthetic elastin hydrogels that are coblended with heparin display substantial swelling, increased porosity, and improved cell penetration.

A defined glycosaminoglycan-binding substratum for human pluripotent stem cells.

PRT-060318, a novel Syk inhibitor, prevents heparin-induced thrombocytopenia and thrombosis in a transgenic mouse model.

[Deep vein thrombosis: how to care for risk patients].

Bioactive scaffolds for engineering vascularized cardiac tissues.

Choosing the right heparin prophylaxis strategy in medical patients at risk for developing VTE: an evidence-based approach.

Economic impact of switching to bivalirudin for a primary percutaneous coronary intervention in a US hospital.

[Treatment of atrial fibrillation: behavioral, pharmacologic and catheter-based perspectives].

[Topical treatment for eosinophilic otitis media].

Synthesis and characterization of degradable bioconjugated hydrogels with hyperbranched multifunctional cross-linkers.